UBX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UBX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Unity Biotechnology's float shares is 16.68 Mil. Unity Biotechnology's total shares outstanding is 16.85 Mil. Unity Biotechnology's float percentage of total shares outstanding is 98.99%.
Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Unity Biotechnology's Insider Ownership is 10.39%.
Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Unity Biotechnology's Institutional Ownership is 21.06%.
It is the percentage of float shares out of the total shares outstanding.
Unity Biotechnology's Float Percentage of Total Shares Outstanding for today is calculated as follows:
Float Percentage of Total Shares Outstanding | = | Float Shares | / | Total Shares Outstanding |
= | 16.68 | / | 16.85 | |
= | 98.99% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alexander Hieu Nguyen | officer: See Remarks | C/O UNITY BIOTECHNOLOGY, INC., 285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Anirvan Ghosh | director, officer: Chief Executive Officer | C/O UNITY BIOTECHNOLOGY, INC., 285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
Lynne Marie Sullivan | officer: See Remarks | C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139 |
Jamie Dananberg | officer: Chief Medical Officer | 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005 |
Michael P. Samar | director | C/O ASSEMBLY BIOSCIENCES, INC., 11711 N. MERIDIAN ST. SUITE 310, CARMEL IN 46032 |
Nathaniel E David | director, officer: President | C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301 |
Gilmore Neil O'neill | director | 215 FIRST STREET, CAMBRIDGE MA 02142 |
Alexander Azoy | officer: See Remarks | 30699 RUSSELL RANCH ROAD, SUITE 140, WESTLAKE VILLAGE CA 91362 |
Graham K Cooper | director | C/O RECEPTOS, INC., 10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO CA 92121 |
Robert Nelsen | director | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
David L. Lacey | director | 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005 |
Kristina Burow | director | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Camille D Samuels | director | 2463 JACKSON ST., SAN FRANCISCO CA 94115 |
Paul L Berns | director | 11080 CIRCLEPOINT RD., STE, 200, WESTMINSTER CO 80020 |
Dan Marquess | officer: Chief Scientific Officer | 3280 BAYSHORE BOULEVARD, BRISBANE CA 94005 |
From GuruFocus
By GuruFocus News • 11-15-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By Marketwired • 07-24-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By GuruFocus Research • 02-09-2024
By Marketwired • 08-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.